The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 |
|---|---|
| Net income | 32,754 |
| Net amortization on securities available for sale | 2,635 |
| Net gain on sales of securities available for sale | 534 |
| Provision for credit losses on loans | 4,400 |
| Credit for credit losses on off-balance sheet exposures | 200 |
| Depreciation of premises and equipment | 1,881 |
| Amortization of other intangible assets | 690 |
| Amortization of right-of use asset | 419 |
| Cash surrender value of bank-owned life insurance | 1,206 |
| Amortization of subordinated debt issuance costs | 208 |
| Stock-based compensation | 3,118 |
| Deferred income taxes | -2,701 |
| Accrued interest receivable and other assets | 1,232 |
| Accrued interest payable and other liabilities | -14,527 |
| Net cash provided by operating activities | 20,835 |
| Decrease in bank-owned certificates of deposit | 719 |
| Proceeds from sales of securities available for sale | 64,707 |
| Proceeds from maturities, paydowns, payups and calls of securities available for sale | 108,590 |
| Purchases of securities available for sale | 204,111 |
| Net increase in loans | 344,846 |
| Net decrease (increase) in fhlb stock | 2,076 |
| Purchases of premises and equipment | 3,303 |
| Purchase of bank-owned life insurance | 4,630 |
| Redemption of bank-owned life insurance | 4,361 |
| Net cash used in investing activities | -380,589 |
| Net increase in deposits | 205,997 |
| Principal payments on notes payable | 13,750 |
| Proceeds from fhlb advances | 936,500 |
| Principal payments on fhlb advances | 891,500 |
| Issuance of subordinated debt, net of issuance costs | 78,690 |
| Redemption of subordinated debt. net of issuance costs | 49,980 |
| Preferred stock dividends paid | 3,040 |
| Stock options exercised | 1,247 |
| Stock repurchases | 2,191 |
| Shares repurchased for tax withholdings upon vesting of restricted stock-based awards | 131 |
| Shares repurchased for tax withholdings upon exercise of stock options | 30 |
| Net cash provided by financing activities | 261,812 |
| Net change in cash and cash equivalents | -97,942 |
| Cash and cash equivalents at beginning of period | 229,760 |
| Cash and cash equivalents at end of period | 131,818 |
Bridgewater Bancshares Inc (BWBBP)
Bridgewater Bancshares Inc (BWBBP)